The global evolution of mental health problems during the COVID-19 pandemic: A systematic review and meta-analysis of longitudinal studies

Journal of Affective Disorders, Journal Year: 2022, Volume and Issue: 315, P. 70 - 95

Published: July 14, 2022

Language: Английский

---

Use of alcohol, tobacco, cannabis, and other substances during the first wave of the SARS-CoV-2 pandemic in Europe: a survey on 36,000 European substance users

Substance Abuse Treatment Prevention and Policy, Journal Year: 2021, Volume and Issue: 16(1)

Published: April 26, 2021

SARS-CoV-2 reached Europe in early 2020 and disrupted the private public life of its citizens, with potential implications for substance use. The objective this study was to describe possible changes use first months pandemic Europe.Data were obtained from a cross-sectional online survey 36,538 adult users 21 European countries conducted between April 24 July 22 2020. Self-perceived measured by asking respondents whether their had decreased (slightly or substantially), increased not changed during past month. covered alcohol (frequency, quantity, heavy episodic drinking occasions), tobacco, cannabis, other illicit drug Sample weighted data descriptively analysed compared across substances.Across all countries, substances remained unchanged around half respondents, while remainder reported either decrease increase For use, overall, larger proportion indicated than those reporting an increase. In contrast, more increases tobacco cannabis previous month No distinct direction change use.Our findings suggest alcohol, initial several countries. This offers insights into Other sources, such as sales statistics, should be used corroborate these preliminary findings.

Language: Английский

---

A Scoping Review on the Medical and Recreational Use of Cannabis During the COVID-19 Pandemic

Cannabis and Cannabinoid Research, Journal Year: 2022, Volume and Issue: 7(5), P. 591 - 602

Published: Jan. 4, 2022

Background/Introduction: The shelter-in-place orders and social distancing regulations on account of the COVID-19 pandemic have impacted lifestyles, including use cannabis. purpose this scoping review is to summarize both gray academic literature cannabis during pandemic. Materials Methods: A total 11 databases, 2 medical 7 science databases were searched resulting in 316 titles abstracts which 76 met inclusion criteria. Results: Nine themes emerged: (a) prevalence trends COVID[1]19; (b) demographics; (c) profile mode consumption; (d) context using (i.e., solitary vs. groups); (e) factors contributing use; (f) inhibiting (g) adverse clinical psychiatric outcomes pandemic; (h) similarities between EVALI (E-Cigarette or Vaping Product Use-Associated Lung Injury) symptoms; (i) implications for policy practice. Studies published until February 2, 2021 included review. Discussion: Findings highlighted that feelings boredom, depression, anxiety contributed an increase Furthermore, accessibility was noted affect Adverse associated with increased Conclusion: Practitioners policymakers are called employ harm reduction strategies respond increasing use. There a need population-based studies further examination negative consequences.

Language: Английский

---

A longitudinal study of change in substance use from before to during the COVID-19 pandemic in young adults

The Lancet Regional Health - Americas, Journal Year: 2022, Volume and Issue: 8, P. 100168 - 100168

Published: Jan. 6, 2022

We assessed change in substance use from before to during the COVID-19 pandemic young adults and identified factors associated with initiation/increase use.The sample comprised a longitudinal investigation of 1294 youth recruited at ages 12-13 (1999-2000) 10 Montréal-area high schools. Pre-pandemic data on cannabis, alcohol, combustible cigarette, e-cigarette binge drinking were collected 20.4, 24.0 30.6. During COVID-19, December 2020 June 2021 (age 33.6). studied prevalence any weekly/daily age 20.4 33.6. Individual-level was estimated as differences frequency 30.6 33.6 versus Heterogeneity risk initiated/increased across sociodemographic subgroups using modified Poisson regression.The cannabis increased 17.5% 23.1% pandemic; 3.8% 5.4%. In individual analyses, proportion participants whose did not ranged 48.9% (alcohol) 84.0% (e-cigarettes). The incidence (22.4%), quit/decreased alcohol (35.2%) (53.5%) higher than between Low education living alone risks most substances.Most reported stable patterns pandemic.The NDIT study supported by Canadian Cancer Society (grant numbers 010271, 017435, 704031) Institutes Health Research number 451832).

Language: Английский

---

Changes in emerging adults’ alcohol and cannabis use from before to during the COVID-19 pandemic: Evidence from a prospective birth cohort.

Psychology of Addictive Behaviors, Journal Year: 2022, Volume and Issue: 36(7), P. 786 - 797

Published: Feb. 24, 2022

Objective: Prospective research is needed to better-understand changes in substance use from before during the COVID-19 pandemic, among emerging adults (18-25 years), a high-risk group for use.Method: N=1,096 (weighted sample N=1,080; 54% female) participants enrolled Québec Longitudinal Study of Child Development, who completed pre-pandemic (2019; 21 years) and (mid-March mid-June 2020) surveys.COVID-19-related pre-existing factors were examined as moderators change use.Results: Full analyses revealed decreased binge drinking (p<.001,Bayes factor (BF)=22, Cohen's f 2 =0.02), but no alcohol cannabis use.Stratified reported 150, =0.05) (p<.001,BF=27, =0.01), not use.Conversely, >monthly =.12) ( p<.001, BF>150, =.06), did frequency.Several moderated use, including employment loss (p<.005,BF>39, =.03) loneliness (p<.018,BF>150, =.10) COVID-19.Conclusions: Changes frequency first three months largely differed according COVID-19-related factors, factors.While some youth with vulnerabilities (e.g., more frequent pre-pandemic) remained stable or COVID-19, experienced loss, loneliness, financial concerns highlighting need supports vulnerable populations.

Language: Английский

---

The Acute Impact of the Early Stages of COVID-19 Pandemic in People with Pre-Existing Psychiatric Disorders: A Systematic Review

International Journal of Environmental Research and Public Health, Journal Year: 2022, Volume and Issue: 19(9), P. 5140 - 5140

Published: April 23, 2022

People with pre-pandemic health conditions are more vulnerable and likely to suffer greater psychosocial impact due the current COVID-19 pandemic lockdown measures. Thus, objective of this work was systematically review early stages on people pre-existing psychiatric disorders. The search performed between 23 January 2 September 2021 in PubMed, PsycINFO, EMBASE. A total 4167 published results were identified; however, only 49 included review. Results show that there considerable heterogeneity among studies, which resulted a low consensus. However, it seems first stage disorders two-fold: (1) an overall effect, suffering from general experienced psychological distress anxiety when compared who had no diagnosis, (2) condition-specific namely eating obsessive compulsive Moreover, highlights also some external factors related worsening symptoms. For instance, unemployment or experiencing financial difficulties can be trigger for during mood disorders, being alone social isolation may actually increase substance use relapse rates. Further studies needed prospectively investigate long-term effects (pre)-existing onset deterioration psychiatric-related symptoms larger number participants, as well exploring mental health.

Language: Английский

---

Changes in self-reported cannabis use during the COVID-19 pandemic: a scoping review

BMC Public Health, Journal Year: 2023, Volume and Issue: 23(1)

Published: Nov. 1, 2023

The COVID-19 pandemic is affecting mental health and substance use (MHSU) issues worldwide. purpose of this study was to characterize the literature on changes in cannabis during factors associated with such changes.We conducted a scoping review by searching peer-reviewed databases grey from January 2020 May 2022 using Arksey O'Malley Framework. Two independent reviewers screened total 4235 documents. We extracted data 129 documents onto extraction form collated results content analytical techniques.Nearly half (48%) studies reported an increase/initiation use, while 36% no change, 16% decrease/cessation pandemic. Factors increased included socio-demographic (e.g., younger age), related symptom burden), MHSU anxiety, depression), pandemic-specific reactions stress, boredom, social isolation), cannabis-related dependence), policy-related legalization medical/recreational cannabis).Public emergencies like have potential significantly impact use. has placed urgency improving coping mechanisms supports that help populations adapt major sudden life changes. To better prepare care systems for future pandemics, wide-reaching education how pandemic-related change impacts needed.

Language: Английский

---

Healthcare practitioner perceptions on barriers impacting cannabis prescribing practices

BMC Complementary Medicine and Therapies, Journal Year: 2022, Volume and Issue: 22(1)

Published: Sept. 8, 2022

Canadians seeking medical cannabis (MC) may encounter difficulties in finding a healthcare provider (HCP) who authorizes their access to it. Barriers that HCPs face authorizing MC are unclear. The objectives of this study were evaluate HCP opinions, knowledge, comfort, and practice prescribing counseling on recreational use, whether the COVID-19 pandemic affected practices.Eligible participants included (e.g., attending physicians, nurses, pharmacists) Canada. A questionnaire evaluating was designed based instruments developed previous studies. Between April 13th-December 13th 2021, ninety-one associations asked distribute survey members, an advertisement placed online Canadian Medical Association Journal. Descriptive statistics used analyze results.Twenty-four organizations agreed disseminate 70 individuals completed Of respondents, 71% physicians or residents, while remainder pharmacists other HCPs. Almost none (6%) received training professional school but 60% did receive workshops, conferences). Over half (57%) more questions regarding since legalized, 82% reported having patients use MC. However, 56% felt uncomfortable ambivalent knowledge MC, 27% unfamiliar with requirements for obtaining most common symptoms recommending pain nausea, whereas conditions it cancer intractable pain. strongest barrier uncertainty safe effective dosage routes administration. lack research evidence demonstrating its safety efficacy. During pandemic, many respondents greater number relieve anxiety depression.Our results suggest across Canada responded our topics related barriers appear be clinical research, Increasing training, help feel equipped make informed treatment/prescribing decisions, which improve

Language: Английский

---

COVID-19 lockdown and lifestyles: A narrative review

F1000Research, Journal Year: 2024, Volume and Issue: 10, P. 363 - 363

Published: Sept. 26, 2024

Background The primary objective worldwide during the coronavirus disease 2019 (COVID-19) pandemic had been controlling transmission. However, lockdown measures used to mitigate transmission affected human behavior and altered lifestyles, with a likely impact on chronic non-communicable diseases. More than year into pandemic, substantial peer-reviewed literature emerged lifestyles following varying imposed globally control virus spread. We explored of six lifestyle factors, namely diet, physical activity, sleep, stress, social connectedness, use tobacco, alcohol, or other harmful substances. Methods comprehensively searched PubMed World Health Organization’s global database COVID-19 retrieved 649 relevant articles for narrative review. A critical interpretative synthesis was performed. Results Most included in review identified negative effect each factors many parts world. Encouraging trends were also highlighted few articles. Such can positively influence outcome lifestyle-related diseases, such as obesity diabetes. Conclusions associated has largely individuals communities across countries cultures. some initiated positive behavioral changes. If knowledge generated by studying COVID-19-related lockdowns is further consolidated, it could improve outcomes. This will help better understand behaviors amidst crises assist redesigning extreme public health lockdowns.. It up governments, communities, healthcare/academic entities derive benefit from lessons learned ultimate educating promoting healthy among communities.

Language: Английский

---

Changes in Substance Use and Mental Health Burden among Women during the Second Wave of COVID-19 in Germany

International Journal of Environmental Research and Public Health, Journal Year: 2021, Volume and Issue: 18(18), P. 9728 - 9728

Published: Sept. 15, 2021

Unlike men, who are disproportionately affected by severe disease progression and mortality from COVID-19, women may be more the economic, social psychological consequences of pandemic. Psychological distress mental health problems general risk factors for increases in use alcohol other substances as a dysfunctional coping mechanism. Methods: An analysis was carried out female subset (n = 2153) population-based, cross-sectional online survey (October–December 2020), covering “second wave” COVID-19 pandemic Germany. Results: Among women, 23% increased their use, 28.4% nicotine 44% illicit substance during Twenty percent reported major depressive symptoms 23.4% generalized anxiety. Generalized anxiety proved to significant predictor logistic regression. Discussion: The burden remained high second wave alcohol, increased. However, association between weak. does not seem main motivator use.

Language: Английский

---